Braskem (BRKM5) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
3 Jul, 2026Executive summary
Recurring EBITDA for 2024 reached US$1.1 billion, up 46% year-over-year, driven by higher international spreads, increased sales in Brazil and Mexico, and improved operational performance, despite a challenging 4Q24 with a 76% sequential drop in quarterly EBITDA to US$102 million.
Net loss for 2024 was US$2.2 billion (R$12.1 billion), mainly due to negative exchange rate variation and increased provisions related to the Alagoas geological event.
Cash position at year-end was US$2.4 billion, covering debt maturities for the next 47 months; gross debt stood at US$8.6 billion, with 92% in US dollars and an average term of 9 years.
Safety performance improved, with a 16% reduction in the global accident frequency rate to 0.91 events per million hours worked, aligning with best market standards.
Strategic initiatives included divestment of Cetrel, expansion of green ethylene capacity, and progress on the Alagoas salt cavity closure plan.
Financial highlights
4Q24 recurring EBITDA was US$102 million, down 76% sequentially and 52% year-over-year; annual recurring EBITDA rose 46% to US$1.1 billion.
Net revenue for 2024 was R$77.4 billion, up 10% year-over-year; gross profit was R$5,997 million.
Net loss in 2024 was R$11.3 billion, mainly due to R$11.5 billion in negative exchange rate variation.
Operating cash generation for 2024 was R$4.1 billion, with recurring cash consumption of R$499 million due to higher interest payments and working capital variation.
Leverage ratio ended 2024 at 7.42x, down 0.7x from the previous year.
Outlook and guidance
All segments are expected to show higher utilization rates in Q1 2025 due to stable feedstock supply and absence of planned shutdowns; PE spreads in Brazil and Mexico projected to rise, while PP spreads in USA & Europe may decline.
2025 investments are planned at US$484 million, focusing on maintenance, operational efficiency, and completion of the ethane import terminal in Mexico.
Management believes current working capital and capex financing are sufficient to fund operations and obligations for at least one year.
The company will continue to evaluate the operational and financial impacts of Brazil's tax reform during 2025.
Strategic focus remains on foundation, resilience, financial health, transformation, green business growth, and asset optimization.
Latest events from Braskem
- EBITDA surged 121% to US$224M, but Alagoas-related risks remain significant.BRKM5
Q1 20259 Jul 2026 - EBITDA surged 104% sequentially, but net loss and high leverage persisted amid legal and market headwinds.BRKM5
Q3 20259 Jul 2026 - EBITDA surged 39–46%, but net loss widened on currency impacts; liquidity remains strong.BRKM5
Q2 20248 Jul 2026 - Recurring EBITDA fell 49% and net loss reached R$10,961m amid high leverage and industry downturn.BRKM5
Q4 20258 Jul 2026 - EBITDA rose 76% sequentially, but leverage, cash burn, and legal risks remain high.BRKM5
Q1 20267 Jul 2026 - EBITDA plunged 67%, leverage hit 10.59x, and legal, market, and cash flow risks remain.BRKM5
Q2 20257 Jul 2026 - EBITDA hit a two-year high on margin gains, but legal and currency risks remain.BRKM5
Q3 20243 Jul 2026 - 2030 targets: 1M tons each of bio-based and recycled products, with ambitious decarbonization goals.BRKM5
Investor Day 202412 Jan 2026